Oncoceutics, Inc. is a clinical-stage drug discovery and development company with a novel class compounds that selectively target G protein-coupled receptors for oncology. The first lead compound to result from this program is ONC201.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.